Insider trades

Dennis Podlesak, Director of Syndax Pharmaceuticals SNDX, has filed 0 purchases and 3 sales on the open market. The latest trade was on 02/04.

Dennis Podlesak

Director
First filing
23/02/03
Trades
14 trades
Buys / sales
0 / 3
12-month net buying
No record
Last trade
02/04

Trading activity

Transactions

Trade type
SNDX
Open-market sale10b5-1 plan25/08/14–25/08/1825/08/1857,600 sh3 trades$15.19avg.$874,944−23.1%